Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Irritable Bowel Syndrome, February 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 64 articles: HTML format

Single Articles

1. BAI W, Zheng Y, Lin S, Pan Y, et al
   Child maltreatment and its association with incident irritable bowel syndrome: genetic risk and mediation pathways in the UK biobank.
   J Public Health (Oxf). 2026 Jan 30:fdag004. doi: 10.1093.
   PubMed    
   Abstract available
   
   

2. VERMEIJDEN NK, van der Feen C, Groeneweg M, Hummel T, et al
   Peppermint oil and sweets in pediatric irritable bowel syndrome and functional abdominal pain: a randomized trial.
   Clin Gastroenterol Hepatol. 2026 Jan 27:S1542-3565(26)00042.
   PubMed    
   Abstract available
   
   

3. HUGHES M, Jude E, McMahan ZH, Alam U, et al
   An epidemiological study estimating the burden of cancer risk in patients with Raynaud's phenomenon.
   Clin Rheumatol. 2026 Jan 29. doi: 10.1007/s10067-026-07961.
   PubMed    
   Abstract available
   
   

4. UPPALA PK, Karanam SK, Maddi R
   Science of fecal microbiota transplant: From history to cutting-edge clinical practice.
   World J Gastrointest Endosc. 2026;18:113133.
   PubMed    
   Abstract available
   
   

5. JANOWSKI WM, Kaczmarczyk GM, Tarasiuk-Zawadzka A, Fichna J, et al
   Therapeutic strategies in irritable bowel syndrome: current standards, emerging options and future challenges.
   Folia Med Cracov. 2025;65:5-29.
   PubMed    
   Abstract available
   
   

6. DING Y, Wang J, Luo Q, Deng C, et al
   Shared genetic architecture between schizophrenia and gastrointestinal diseases: insights from large-scale genome-wide cross-trait analysis.
   Ann Gen Psychiatry. 2026 Jan 28. doi: 10.1186/s12991-025-00625.
   PubMed    
   Abstract available
   
   

7. KOU RW, Zhang RJ, Xia B, Bai GY, et al
   Ganoderic Acid A Modulates Enteric Neurons and Intestinal Homeostasis in Irritable Bowel Syndrome by Microbiota Sensing.
   J Agric Food Chem. 2026 Jan 28. doi: 10.1021/acs.jafc.5c15628.
   PubMed    
   Abstract available
   
   

8. ZHOU Y, Liu S, Xie S, Zhang Q, et al
   Long-term risk of irritable bowel syndrome associated with adverse childhood and adulthood experiences: a large-scale prospective cohort study.
   Transl Psychiatry. 2026 Jan 28. doi: 10.1038/s41398-026-03833.
   PubMed    
   Abstract available
   
   

9. HOU S, Ning T, Liu S, Yang X, et al
   Fusobacterium nucleatum plays a pathogenic role in a murine model of irritable bowel syndrome by modulating intestinal purine metabolism and promoting mast cell activation.
   Gut Microbes. 2026;18:2620124.
   PubMed    
   Abstract available
   
   

10. ACCARIE A, Huyghe P, Meleine M, Van den Houte K, et al
    Oral Local Budesonide Treatment Ameliorates Immune Activation and Colonic Sensitivity in a Spontaneous Model for Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2026;38:e70233.
    PubMed    
    Abstract available
    
    

11. PIA F, Decraecker L, Looze D, Hirsch D, et al
    Dose-Dependent Effect of the Histamine 1 Receptor Antagonist Ebastine in Patients With Non-Constipated Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2026;38:e70242.
    PubMed    
    Abstract available
    
    

12. SMITH SJ, Sichlau MJ, Rowe PC, Knight DRT, et al
    Case Report: Neuropsychiatric improvement after treatment of pelvic venous disorder in a multisyndromic patient.
    Front Cardiovasc Med. 2026;12:1574432.
    PubMed    
    Abstract available
    
    

13. LACY BE, Shin AS, Cangemi DJ, Yang Y, et al
    Tenapanor is associated with earlier and sustained symptom relief in IBS-C: a post hoc analysis.
    Therap Adv Gastroenterol. 2026;19:17562848251414831.
    PubMed    
    Abstract available
    
    

14. SONG CH, Kim N, Nam RH, Choi H, et al
    Sex-Dependent Microbial and Host Profiles Following Fecal Microbiota and Bifidobacterium longum Treatment in Stress-Induced Gut Dysbiosis.
    Gut Liver. 2026 Jan 28. doi: 10.5009/gnl250440.
    PubMed    
    Abstract available
    
    

15. PASTRAS P, Aggeletopoulou I, Bali M, Triantos C, et al
    Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
    Nutrients. 2026;18:183.
    PubMed    
    Abstract available
    
    

16. LIM YH, Yoo JH, Park JW, Hwang JM, et al
    Gastrointestinal Diagnostic Coding After Spinal Cord Injury: Health Behavior Correlates and Implications for Neurogenic Bowel Management in a Nationwide Claim-Based Cohort.
    J Clin Med. 2026;15:760.
    PubMed    
    Abstract available
    
    

17. SACCO R, Facciorusso A, Giannini E, Bellini M, et al
    Revisiting Abdominal Pain in IBS: From Pathophysiology to Targeted Management with Alverine Citrate/Simeticone.
    J Clin Med. 2026;15:722.
    PubMed    
    Abstract available
    
    

18. PICCIRILLO M, Renzi E, De Vito C, Mennini M, et al
    Efficacy and Safety of Probiotics in Children with Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Microorganisms. 2025;14:23.
    PubMed    
    Abstract available
    
    

19. ALMALKI AS, Jaafari NY, Aldossari NG, Alharbi AA, et al
    Efficacy of Specific Probiotic Strains in Subtypes of Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Medicina (Kaunas). 2025;62:89.
    PubMed    
    Abstract available
    
    

20. ZHU Z, Liu Z, He Y, He X, et al
    G Protein-Coupled Receptors in Irritable Bowel Syndrome: Mechanisms and Therapeutic Opportunities.
    Int J Mol Sci. 2026;27:752.
    PubMed    
    Abstract available
    
    

21. JIA SM, Wang KQ, Hu SF, Weng RX, et al
    A Glutamatergic Medial Prefrontal Cortex-Locus Coeruleus Circuit Drives Intestinal Dysmotility in Diarrhea-Predominant Irritable Bowel Syndrome.
    Int J Mol Sci. 2026;27:681.
    PubMed    
    Abstract available
    
    

22. LUNDERVOLD A, Billing J, Berentsen B, Lundervold AJ, et al
    Patient Similarity Networks for Irritable Bowel Syndrome: Revisiting Brain Morphometry and Cognitive Features.
    Diagnostics (Basel). 2026;16:357.
    PubMed    
    Abstract available
    
    

23. ZHAO Y, Zhang Y, Gao Z, Yuan X, et al
    Effect of combined continuity care guided by Orem's self-care model and low FODMAP diet on gut microbiota composition and symptoms in patients with irritable bowel syndrome.
    BMC Gastroenterol. 2026 Jan 28. doi: 10.1186/s12876-026-04621.
    PubMed    
    Abstract available
    
    

24. RAMEZANI A, Yazdanmanesh M, Heidari H, Khadiv A, et al
    Phenotypic and Genotypic Characterization of ESBL- and Carbapenemase-producing Escherichia coli Isolates in Irritable Bowel Syndrome (IBS) Patients.
    Infect Disord Drug Targets. 2026.
    PubMed    
    Abstract available
    
    

25. KOCA TT, Gogebakan H, Nazik H, Cetin G, et al
    Clinical Importance of Central Sensitization and Neuropathic Pain in The Treatment and Follow-Up of Patients with Psoriasis and Psoriatic Arthritis.
    Indian J Dermatol. 2026;71:58-64.
    PubMed    
    Abstract available
    
    

26. KIM Y, Lee MH, Seo SH, Pak J, et al
    Integrated Metabolomics and Microbial Profiling in Patients with Irritable Bowel Syndrome.
    J Microbiol Biotechnol. 2026;36:e2511041.
    PubMed    
    Abstract available
    
    

27. GHOSHAL UC, Singh R, Goenka MK
    Post-Coronavirus Disease (COVID)-19 Irritable Bowel Syndrome: What We've Learned So Far.
    Neurogastroenterol Motil. 2026;38:e70250.
    PubMed    
    Abstract available
    
    

28. HERNANDO A, Morais Costa B, Charneca S, Santos I, et al
    Mapping the Evidence on IgG-Based Elimination Diets for the Management of Irritable Bowel Syndrome in Adults: A Systematic Scoping Review.
    Nutr Rev. 2026 Jan 24:nuaf268. doi: 10.1093.
    PubMed    
    Abstract available
    
    

29. BADWEI N, Abdelsalam A, Wassif GO, El-Din HES, et al
    Quality of Life and Psychological Burden in Irritable Bowel Syndrome: The Impact of Intestinal Parasitic Infections (Phase II Study).
    Trop Med Int Health. 2026 Jan 23. doi: 10.1111/tmi.70079.
    PubMed    
    Abstract available
    
    

30. GRONBAEK IMB, Halkjaer SI, Hansen EH, Mollerup S, et al
    Eight weeks of treatment with probiotic Bifidobacterium breve, Bif195 lowers fatigue scores in patients with diarrhoea-predominant irritable bowel syndrome: results from a randomised, clinical trial.
    Front Nutr. 2026;12:1701341.
    PubMed    
    Abstract available
    
    

31. CUI L, Zhong R, Peng W, Zhang Z, et al
    Hyaluronic acid-ethylenediamine-cinnamic acid attenuates IBS-D via regulating 5-hydroxytryptamine signaling pathway, intestinal barrier and gut microbiota.
    Int J Biol Macromol. 2026 Feb 3:150694. doi: 10.1016/j.ijbiomac.2026.150694.
    PubMed    
    Abstract available
    
    

32. SANTACROCE G, Cocchi A, Di Sabatino A
    Impact of yoga therapy in intestinal disorders.
    Expert Rev Gastroenterol Hepatol. 2026 Feb 5. doi: 10.1080/17474124.2026.2628016
    PubMed    
    Abstract available
    
    

33. WANG W, Li H, Liu YP, Chen Y, et al
    Clinical efficacy of Xifeng Huashi and its effect on mental status in patients with diarrheal irritable bowel.
    World J Psychiatry. 2026;16:113123.
    PubMed    
    Abstract available
    
    

34. RAUMA J, Jansson S, Cao Y, van Nieuwenhoven MA, et al
    Adherence of Swedish primary health care practitioners to diagnostic guidelines for IBS.
    Scand J Prim Health Care. 2026;44:2624726.
    PubMed    
    Abstract available
    
    

35. HALAWI H, Matar A, Wang I, Jencks KJ, et al
    A Pilot, Randomized, Placebo-Controlled Trial of Rimegepant on Visceral Sensation and Symptoms in Non-Constipation IBS Pain.
    Am J Physiol Gastrointest Liver Physiol. 2026.
    PubMed    
    Abstract available
    
    

36. STENNETT E, Belogianni K, Lomer M
    Development and Implementation of Novel Virtual Triage and Exploration of Attitudes Towards the Potential Use of Artificial Intelligence in the Irritable Bowel Syndrome (IBS) Dietetic Pathway.
    J Hum Nutr Diet. 2026;39:e70210.
    PubMed    
    Abstract available
    
    

37. REID JESJ, Alhasani AT, MacCalman T, Amor D, et al
    A randomised, placebo-controlled trial in healthy humans of modified cellulose or psyllium evaluating the role of gelation in altering colonic gas production during inulin co-administration.
    Food Funct. 2026 Feb 4. doi: 10.1039/d5fo03532.
    PubMed    
    Abstract available
    
    

38. CHANG HC, Hsu YH, Chen SJ, Wu MC, et al
    Risk of irritable bowel syndrome in patients with hidradenitis suppurativa: a global-federated, multicenter cohort study.
    Sci Rep. 2026 Feb 3. doi: 10.1038/s41598-026-38442.
    PubMed    
    Abstract available
    
    

39. TSAI MH, Lim HC, Lin KC, Chin HY, et al
    Entheseal pain of levator ani muscle: A novel etiology in chronic pelvic pain and lower urinary tract symptoms-A urodynamic perspective.
    J Chin Med Assoc. 2026 Feb 3. doi: 10.1097/JCMA.0000000000001353.
    PubMed    
    Abstract available
    
    

40. BARAUT MC
    Nutrition and endometriosis: evidence, limits and clinical perspectives.
    Clin Nutr ESPEN. 2026 Jan 31:102954. doi: 10.1016/j.clnesp.2026.102954.
    PubMed    
    Abstract available
    
    

41. D'SILVA A, Hua N, Modayil MV, Seidel J, et al
    Navigation, Adoption, and Use of Digital Health Technologies for Irritable Bowel Syndrome Self-Management: Focus Group Study of Patient Experience and Decision-Making.
    JMIR Hum Factors. 2026;13:e75012.
    PubMed    
    Abstract available
    
    

42. MCINNES H, Klapan L, Moore U, Singh J, et al
    Limited Availability and Higher Cost of Gluten-Free Foods Continue in the United Kingdom: A Comparative Follow-Up Over More Than a Decade.
    J Hum Nutr Diet. 2026;39:e70209.
    PubMed    
    Abstract available
    
    

43. ALMARIO CV
    Health Disparities in Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2025;21:720-723.
    PubMed    
    
    
    

44. YIN Z, Song X, Zhu C, Hou A, et al
    Analgesic effects of bulleyaconitine A: new advances in research from ion channel targets to clinical translation.
    Front Pharmacol. 2026;16:1733973.
    PubMed    
    Abstract available
    
    

45. LICHTENSTEIN GR
    Examining the Use of Natural Products for the Treatment of Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2025;21:535.
    PubMed    
    
    
    

46. BRIGSTOCKE S, Brenner DM
    Natural Products for the Treatment of Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2025;21:540-549.
    PubMed    
    Abstract available
    
    

47. KIM HK, Kim H, Lee A
    Evaluating a mobile-enhanced cognitive behavioral therapy program for university students with irritable bowel syndrome.
    Internet Interv. 2026;43:100905.
    PubMed    
    Abstract available
    
    

48. LACY BE, Saleh H, Cangemi DJ
    Precision Medicine in Disorders of Gut-Brain Interaction.
    Gastroenterol Hepatol (N Y). 2025;21:642-650.
    PubMed    
    Abstract available
    
    

49. TAMANNAEIFAR MR, Shirani Z, Esmikhani M, Zaremohzzabieh Z, et al
    The mediating role of resilience in the relationship between cognitive flexibility and psychological well-being in patients with irritable bowel syndrome: a cross-sectional study.
    BMC Gastroenterol. 2026 Jan 31. doi: 10.1186/s12876-026-04654.
    PubMed    
    Abstract available
    
    

50. BANSAL K, Mukharya A, Jindal AB
    Delivery Strategies and Clinical Significance of Oral Colon-targeted Drug Delivery Systems.
    AAPS PharmSciTech. 2026;27:92.
    PubMed    
    Abstract available
    
    

51. ZHAO Y, Wan R, Li N, Thitinun B, et al
    Digital versus face-to-face gut-directed psychotherapy for irritable bowel syndrome: a protocol of systematic review and network meta-analysis.
    BMJ Open. 2026;16:e104923.
    PubMed    
    Abstract available
    
    

52. ARRAS W, Oosterlinck B, Gassman J, De Man JG, et al
    Clinical Significance of Mucin Signatures in Inflammatory Bowel Diseases: A Systematic Review of Their Expression Patterns, Polymorphisms, and Post-translational Modifications.
    Inflamm Bowel Dis. 2026;32:375-389.
    PubMed    
    Abstract available
    
    

53. MIKHAEL-MOUSSA H, Desprez C, Gillibert A, Leroi AM, et al
    Is Carbohydrate Intolerance Associated With Carbohydrate Malabsorption in Disorders of Gut-Brain Interaction?
    Am J Gastroenterol. 2026;121:461-471.
    PubMed    
    Abstract available
    
    

54. MCSHANE C, O'Connell F, Kevans D, O'Sullivan J, et al
    Ex Vivo Human Colonic Explants Identify Metabolic Alterations and Cytokine Dysregulation in Ulcerative Colitis: A Pilot Study.
    Dig Dis Sci. 2026 Jan 26. doi: 10.1007/s10620-025-09665.
    PubMed    
    Abstract available
    
    

55. ANDOH A, Miwa H
    Association between the Gut Microbiota and the Pathophysiology of Irritable Bowel Syndrome - a Narrative Review.
    Digestion. 2026 Feb 5:1-15. doi: 10.1159/000550907.
    PubMed    
    Abstract available
    
    

56. JIANG S, Wang X, Qu Z, Guo J, et al
    Electroacupuncture Regulated Bile Acid Metabolism and FXR Expression in IBS-C rat: A Preclinical Study.
    Digestion. 2026 Feb 5:1-23. doi: 10.1159/000550560.
    PubMed    
    Abstract available
    
    

57. AKRAM U, Ul Ain H, Ahmed S, Fatima E, et al
    Efficacy and tolerability of plecanatide for irritable bowel syndrome with constipation and chronic idiopathic constipation: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2026 Jan 13. doi: 10.1097/MEG.0000000000003115.
    PubMed    
    Abstract available
    
    

58. GUAN M, Chang L
    Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use.
    Gastroenterol Clin North Am. 2026;55:91-105.
    PubMed    
    Abstract available
    
    

59. SJOLUND J, Hreinsson JP, Bergstrom A, Tornblom H, et al
    Adolescent Risk Factors for the Presence and Persistence of Irritable Bowel Syndrome in Young Adulthood-Findings From a Prospective Birth Cohort.
    Gastroenterology. 2026 Jan 30:S0016-5085(26)00033.
    PubMed    
    
    
    

60. KESZTHELYI D
    "The cure better not worse than the illness" - lessons from ethosuximide in irritable bowel syndrome.
    Gastroenterology. 2026 Jan 29:S0016-5085(26)00087.
    PubMed    
    
    
    

61. MARASCO G, Schmulson M, Ghoshal UC, Khatun R, et al
    Post-infection disorders of gut-brain interaction: results of the Rome Foundation Global Epidemiology Study.
    Gut. 2026 Jan 29:gutjnl-2025-336509. doi: 10.1136/gutjnl-2025-336509.
    PubMed    
    Abstract available
    
    

62. WENG RX, Lin W, Sun Q, Ma CT, et al
    Low-frequency repetitive transcranial magnetic stimulation attenuates visceral pain in IBS with diarrhoea via inhibition of the medial prefrontal cortex.
    Gut. 2026 Feb 2:gutjnl-2025-337612. doi: 10.1136/gutjnl-2025-337612.
    PubMed    
    Abstract available
    
    

63. BRINDICCI VF, Cristofori F, Franceschini S, Gnasso I, et al
    Self-reported Nonceliac Gluten Sensitivity in Patients With Irritable Bowel Syndrome: A Cross-sectional Analysis.
    J Clin Gastroenterol. 2026 Jan 30. doi: 10.1097/MCG.0000000000002306.
    PubMed    
    Abstract available
    
    

64. ZHAO X, Yang Y, Liu Z, Sun R, et al
    Identifying chemicals associated with irritable bowel syndrome by integrating a transcriptome-wide association study with chemical-gene-interaction analysis.
    PLoS One. 2026;21:e0340666.
    PubMed    
    Abstract available